Feeds
310164 items (310164 unread) in 46 feeds
World Health Organization
(748 unread)
-
WHO news (360 unread)
-
Media
(241843 unread)
-
Reuters Health eLine
(10081 unread)
-
CNN Health (3622 unread)
-
NPR Health and Science (4852 unread)
-
ABC News: Health (7714 unread)
-
CBSnews.com: Health News (8167 unread)
-
BBC Health News (7299 unread)
-
CBC Health and Science News (6865 unread)
-
Australia ABC News: Health
(14560 unread)
-
China Xinghua Health News
(8874 unread)
-
New York Times: Health
(13181 unread)
-
USATODAY.com Health - Top Stories (5521 unread)
-
The Seattle Times: Health (5304 unread)
-
International Herald Tribune: Health and Science (4820 unread)
-
HeraldToday.com: Health
(2842 unread)
-
WebMD Health Headlines
(6582 unread)
-
MedicineNet Daily News (13746 unread)
-
Medical News Today
(75922 unread)
-
iVillage Health
(956 unread)
-
Topix.net - Health (5909 unread)
-
Newsvine - health
(35026 unread)
Bird Flu
(5365 unread)
-
MSNBC.com: Bird Flu (171 unread)
-
-
Medical News Today - Bird Flu/Avian Flu
(739 unread)
-
Diabetes
(11091 unread)
-
-
Medical News Today - Diabetes
(3956 unread)
-
Cholesterol
(4298 unread)
-
Topix.net - Cholesterol
(1765 unread)
-
Medical News Today - Cholesterol
(630 unread)
-
Cancer
(23007 unread)
-
-
-
Medical News Today - Breast Cancer News
(3067 unread)
-
Medical News Today - Cancer/Oncology News
(10514 unread)
-
HIV
(12622 unread)
-
-
Medical News Today - HIV/AIDS News
(7136 unread)
-
Women
(8661 unread)
-
-
Medical News Today - OBGYN News
(5690 unread)
-
Men
(2529 unread)
-
-
Medical News Today - Men's health News
(1071 unread)
-
Partners Site
NewMesotheliomaInformation.org
Health Link Exchange Directory
Sponsors
Medical News Today - Cholesterol (30 unread)
-
New Drug Reduces Bad Cholesterol And Triglycerides Without Statin Side Effects
Posted: March 11th, 2010, 5:00am CST
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published in the New England Journal of Medicine. "Our study has shown a dramatic reduction in the dangerous fats that cause heart disease, the number one killer of Americans," said Dr... -
Experimental Drug That Mimics Thyroid Hormone Safely Lowers 'Bad' Cholesterol In Statin-Treated Patients
Posted: March 11th, 2010, 5:00am CST
People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar... -
Agency For Healthcare Research And Quality News And Numbers: High Cholesterol, Diabetes Lead Drug Spending For The Elderly
Posted: March 11th, 2010, 4:00am CST
Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 - about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers... -
Health Care Partnership Examined In Canadian Medical Association Journal
Posted: March 9th, 2010, 7:00am CST
A research team from the Laval Centre de sante et de services sociaux, Universite de Montreal and McGill University Health Centre has examined the benefits of greater collaboration between family physicians and community pharmacists for select patients... -
Obesity As Protection Against Metabolic Syndrome, Not Its Cause
Posted: March 9th, 2010, 4:00am CST
The collection of symptoms that is the metabolic syndrome - insulin resistance, high cholesterol, fatty liver, and a greater risk for diabetes, heart disease, and stroke - are all related to obesity, but, according to a review in the March 9th issue of the Cell Press publication Trends in Endocrinology and Metabolism, not in the way you probably think they are... -
New Report Warns: If You Take Simvastatin To Control Cholesterol, Watch Out For Infection
Posted: March 2nd, 2010, 7:00am CST
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology (http://www.jleukbio.org). In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system... -
Mipomersen Phase 3 Study In Patients With Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint
Posted: February 12th, 2010, 2:00am CST
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo... -
FDA Approves New Indication For Crestor
Posted: February 10th, 2010, 6:00am CST
On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it... -
Butter Leads To Lower Blood Fats Than Olive Oil
Posted: February 10th, 2010, 4:00am CST
High blood fat levels normally raise the cholesterol values in the blood, which in turn elevates the risk of atherosclerosis and heart attack. Now a new study from Lund University in Sweden shows that butter leads to considerably less elevation of blood fats after a meal compared with olive oil and a new type of canola and flaxseed oil... -
Mizzou Scientist Creates A Chicken Substitute, Providing A Low-Cost, Tasty Way To Add Soy To The Diet
Posted: February 5th, 2010, 7:00am CST
Sure, some delicacies might taste just like chicken, but they usually feel and look much different. Soy meat alternatives, such as the soy burger, have become more popular recently, with increased sales of eight percent from 2007 to 2008. Now, scientists at the University of Missouri have created a soy substitute for chicken that is much like the real thing... -
In Light Of Research About Teens' Heart Disease Risk, Lifestyle Changes Critical
Posted: February 4th, 2010, 2:00am CST
Pamphlets detailing the warning signs associated with heart disease may soon end up in an unexpected location: your child's pediatrician's office. According to new research from the Centers for Disease Control and Prevention (CDC), one in five American teens has at least one risk factor for developing heart disease in adulthood... -
Cholesterol's Link To Heart Disease Gets Clearer - And More Complicated
Posted: February 3rd, 2010, 6:00am CST
By considering molecular-level events on a broader scale, researchers now have a clearer, if more complicated, picture of how one class of immune cells goes wrong when loaded with cholesterol... -
Siemens Introduces Cholesterol To The ADVIA Chemistry Concentrated Reagents Portfolio
Posted: January 29th, 2010, 4:00pm CST
Siemens Healthcare Diagnostics has introduced concentrated Cholesterol, the 15th ADVIA® Chemistry reagent in concentrated format. ADVIA Chemistry concentrated reagents offer up to 3060 tests per wedge, whilst still giving identical results to the conventional ADVIA non-concentrated reagents... -
Pomegranate Extract Stimulates Uterine Contractions
Posted: January 28th, 2010, 6:00am CST
The team identified beta-sitosterol - a steroid that can inhibit the absorption of cholesterol in the intestine - as the main constituent of pomegranate seed extract. The research suggests that pomegranate extract could be used as a natural stimulant to encourage the uterus to contract during labour... -
Even Younger People Should Consider Cholesterol Screening
Posted: January 24th, 2010, 3:00am CST
If you think heart disease is a disease of the middle aged, think again. Experts recommend that cholesterol screening should begin as early as 20 years of age because it is a key indicator of heart-attack risk, and should be rechecked at least once every five years. Atherosclerosis begins early, says Dr... -
Research Published By Standard Process Inc. Scientists About The Effects Of Dietary Intervention On Cholesterol Levels
Posted: January 19th, 2010, 8:00am CST
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food... -
Higher Statin Doses Not Always Best At Preventing Coronary Artery Disease
Posted: January 19th, 2010, 4:00am CST
Statins have proven highly effective at lowering cholesterol. Typically, a treat-to-target approach, which means treating to a target cholesterol level, is taken with statin therapy. However, some experts believe that a tailored approach that uses different dosages based on pateints' risk for cardiovascular disease may be a better strategy for reducing the risk of coronary artery disease... -
Treat The Risk, Not The Cholesterol: Study Challenges Current Cholesterol Recommendations
Posted: January 19th, 2010, 3:00am CST
A new study by the University of Michigan Medical School and VA Ann Arbor Health System challenges the medical thinking that the lower the cholesterol, the better... -
Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets
Posted: January 18th, 2010, 6:00am CST
Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL® (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of WELCHOL® with the U.S. Food & Drug Administration ("FDA")... -
Despite FDA Warnings, The Monitoring Of High-Risk Medications Remains Unchanged
Posted: January 13th, 2010, 7:00am CST
A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general... -
Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 For The Treatment Of Cardiovascular Disease
Posted: January 12th, 2010, 3:00am CST
Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate... -
Tekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial
Posted: January 8th, 2010, 5:00am CST
Tekmira Pharmaceuticals Corporation (TSX:TKM) announced that it has concluded its ApoB SNALP Phase 1 human clinical trial. ApoB SNALP is designed to reduce the production of apolipoprotein B (ApoB), a protein produced in the liver that plays a central role in cholesterol metabolism. Tekmira enrolled a total of 23 subjects in its Phase 1 clinical trial... -
Good Cholesterol Not As Protective In People With Type 2 Diabetes
Posted: December 23rd, 2009, 3:00am CST
High-density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with type 2 diabetes, according to research reported in Circulation: Journal of the American Heart Association. HDL carries cholesterol out of the arteries, and high levels are associated with a lower risk of heart disease... -
Good Cholesterol Not As Protective In People With Type 2 Diabetes
Posted: December 23rd, 2009, 3:00am CST
High-density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with type 2 diabetes, according to research reported in Circulation: Journal of the American Heart Association. HDL carries cholesterol out of the arteries, and high levels are associated with a lower risk of heart disease... -
Low CETP Activity Associated With Heart Disease Risk
Posted: December 15th, 2009, 8:00pm CST
Although seen as a potential heart disease therapy, raising high-density lipoprotein (HDL) cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests... -
Low CETP Activity Associated With Heart Disease Risk
Posted: December 15th, 2009, 8:00pm CST
Although seen as a potential heart disease therapy, raising high-density lipoprotein (HDL) cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests... -
Modifiable Risk Factors For Heart Disease Identified By New Research
Posted: December 14th, 2009, 3:00am CST
Special issue focuses on cardiovascular disease prevention and outcomes Emerging research on cardiovascular risk factors and treatment effects are helping clinicians gain a better understanding of which patients are most likely to benefit from close monitoring, lifestyle changes and/or additional therapeutic interventions... -
Modifiable Risk Factors For Heart Disease Identified By New Research
Posted: December 14th, 2009, 3:00am CST
Special issue focuses on cardiovascular disease prevention and outcomes Emerging research on cardiovascular risk factors and treatment effects are helping clinicians gain a better understanding of which patients are most likely to benefit from close monitoring, lifestyle changes and/or additional therapeutic interventions... -
Patients With High CRP And Normal LDL Have Long-Term Risk For Heart Disease, Stroke And Death
Posted: December 13th, 2009, 2:00am CST
New research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death... -
Patients With High CRP And Normal LDL Have Long-Term Risk For Heart Disease, Stroke And Death
Posted: December 13th, 2009, 2:00am CST
New research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death...